UEG's content platform for gastroenterology education bringing recordings, courses, guidelines, and more together in one place.

Re-live UEG Week 2026 on Gutflix Gut Guide online What's new on Gutflix

Trending on Gutflix

Rate for better recommendations!

Your feedback helps us show you more of what you like and less of what you dislike!

More of this!

We will show you more similar content.

Not for me!

We won't suggest this again.

Bookmark!

Save this content for later!

New to myUEG? Create an account! Log In with myUEG account

UEG Poster

Standard Poster

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

RISK ASSESSMENT QUESTIONNAIRE IN A WESTERN COMMUNITY TO IDENTIFY A GASTIC CANCER RISK POPULATION: THE GASTROSCREENING PROJECT

Gian Luca Baiocchi 1, Roberto Grassia 1, Ilaria Benzoni 1, Luigi Martinelli 2, Andrea Celotti 1, Biagio Elvo 1, Andrea Drago 1, Carmen Laurenza 1, Imma Di Luna 1, Luca Pignata 1, Sara Soro 1, Nicola Mattia Cantisani 3, Luca Mattia Quarti 1, Antonio Tarasconi 1, Giulia Tanzi 1, Silvio Garattini 4, Giuseppe Verlato 2

Affiliations

1 ASST Cremona, Cremona, Italy

2 University of Verona, Verona, Italy

3 Federico II University, Napoli, Italy

4 IRCCS “Mario Negri” Research Institute, Milano, Italy

Summary

AI Generated

The GASTROFORM online questionnaire was developed to identify individuals aged 40-80 years who require esophagogastroduodenoscopy based on gastric cancer risk factors and alarm symptoms, with initial testing on 4426 respondents in Italy.

GASTROFORM is an online questionnaire collecting data on demographics, family history, gastrointestinal symptoms, alarm symptoms, and recent endoscopy history to stratify gastric cancer risk.
In the first study phase involving 4426 valid questionnaires submitted in November 2022, 13.82% of respondents reported at least one alarm symptom indicating need for prompt esophagogastroduodenoscopy.
The authors expect the tool to increase diagnosis rates for Barrett esophagus from 1.8% to 5-8%, atrophic gastritis from 9% to 20-30%, and early gastric cancer from 0.019% to 1-2%.
The questionnaire targets individuals aged 40 to 80 years in Italy, where gastric cancer remains one of the most frequent tumors despite no approved large-scale screening program.
This preliminary report presents the first phase of a project developing a screening tool; gastroenterologists and researchers interested in gastric cancer early detection programs would benefit from the full material.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Introduction

Nowadays there is no screening test approved on large scale for gastric cancer even if this neoplasia represents one of the leading causes of cancer-related deaths globally^1-2. In Italy still remains one of the most frequent tumors, with incidence rates differing across geographical areas³.

Aims & Methods

This project aims to create an easily administrable tool to detect anamnestic gastric cancer risk factors together with alarm symptoms in an age-defined target population to identify patients in need of an esophagogastroduodenoscopy (EGD).
This paper describes the first study phase: the administration of the questionnaire to a first sample of 5000 people aged from 40 to 80 years and the preliminary results. GASTROFORM is an online questionnaire (https://it.research.net/r/GASTROFORM) collecting data about demographic and anthropometric features, physiological anamnesis, familial history, non-specific upper gastrointestinal symptomatology, alarm symptoms and recent EGD performance.

Results

4426 valid questionnaires were submitted through the online form in November 2022, 612 of them (13,82%) reported at least one alarm symptom identifying patients in need to undergo an EGD as soon as possible. From an epidemiological point of view we expect to increase the rate of diagnosis in Barret esophagus (from 1,8% to 5-8%), atrophic gastritis (from 9% to 20-30%) and early gastric cancer (from 0,019% to 1-2 %).

Conclusion

The GASTROFORM questionnaire could provide useful informations to identify a population most likely to have significant endoscopic findings in early diagnosis during a screening EGD.

References

1. Ilic M, Ilic I. Epidemiology of stomach cancer. World J Gastroenterol. 2022;28(12):1187-1203. doi:10.3748/wjg.v28.i12.1187
2. Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019;14(1):26-38. doi:10.5114/pg.2018.80001
3. Donida BM, Tomasello G, Ghidini M, et al. Epidemiological, clinical and pathological characteristics of gastric neoplasms in the province of Cremona: the experience of the first population-based specialized gastric cancer registry in Italy. BMC Cancer. 2019;19(1):212. Published 2019 Mar 8. doi:10.1186/s12885-019-5366-1

Conference

UEG Week Vienna 2024

Topics

Oesophagus

Submission format

Abstract

Session

OESOPHAGEAL, GASTRIC AND DUODENAL (Posters)

Citation

United European Gastroenterology Journal 2024; 12 (Supplement 8)

Published

2024

More Like This:

[68GA]FAPI PET-MRI QUANTIFIES FIBROBLAST ACTIVITY BURDEN AND DIFFERENTIATES FIBROSTENOSIS FROM AN INFLAMMATORY PHENOTYPE IN CROHN’S DISEASE

Rahul Kalla

See: A typical case of autoimmune pancreatitis?

Sophie Rauschenberg

ENDOSCOPIC TREATMENT PARADIGM FOR CHOLECYSTODUODENAL FISTULA: APPLICATION OF ENTERAL NUTRITION SUPPORT COMBINED WITH DUODENAL STENT PLACEMENT

Hangbin Jin

TEMPORAL TRENDS IN DYSPLASIA AMONG IBD PATIENTS: NATIONWIDE EVIDENCE OF INCREASING LGD INCIDENCE AMIDST PLATEAUING ADVANCED DISEASE IN DENMARK

Anders Kirch Dige

THE USE OF SHEAR WAVE ELASTOGRAPHY IN DIFFERENTIATING FIBROTIC FROM INFLAMMATORY STRICTURES IN CROHN’S DISEASE

Giovanni Maconi

Post-pancreatectomy steatosis hepatis

Karen Geboes

UEG Presentation

New

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

[68GA]FAPI PET-MRI QUANTIFIES FIBROBLAST ACTIVITY BURDEN AND DIFFERENTIATES FIBROSTENOSIS FROM AN INFLAMMATORY PHENOTYPE IN CROHN’S DISEASE

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.